Advantages of DNA Vaccines in Response to the COVID-19 Outbreak – a conversation between:
– Kate E. Broderick, Ph.D., INOVIO Senior Vice President, R&D and Team Lead for COVID-19 Vaccine Development
– Stanley A. Plotkin, M.D., Emeritus Professor, the Wistar Institute and University of Pennsylvania; INOVIO Scientific Advisory Board Member
This discussion is an excerpt from the June 1 webinar hosted by INOVIO, titled “DNA Medicines: From COVID-19 to Cancer” (available in full at
